naftopidil has been researched along with Premature Ejaculation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, T; Araki, T; Haga, K; Honma, I; Kondou, N; Matsukawa, M; Otani, T; Sato, Y; Tobe, M; Uchida, K | 1 |
| Fukuhara, S | 1 |
| Seftel, AD | 1 |
1 trial(s) available for naftopidil and Premature Ejaculation
| Article | Year |
|---|---|
Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies; Self Administration; Time Factors; Treatment Outcome; Urological Agents; Young Adult | 2017 |
2 other study(ies) available for naftopidil and Premature Ejaculation
| Article | Year |
|---|---|
Editorial Comment to Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies | 2017 |
Re: Silodosin versus Naftopidil in the Treatment of Premature Ejaculation: A Prospective Multicenter Trial.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies | 2017 |